A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients

Chemotherapy

Volumn 45, Issue 5, 1999, Pages 370-379

  Wang, Fu Der ^a,b   Liu, Cheng Yi ^a,b   Hsu, Hui Chi ^a,b   Gau, Jyh Pyng ^a,b   Chau, Wing Keung ^a,b   Haung, Ming Lih ^a,b   Ho, Chao Hung ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cefepime; Ceftazidime; Empiric therapy; Febrile episode; Neutropenia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CEFEPIME; CEFTAZIDIME;

ADOLESCENT; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; GENDER; HEIGHT; HUMAN; LEUKOCYTE COUNT; MALE; NAUSEA; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; CEFTAZIDIME; CEPHALOSPORINS; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEUTROPENIA; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VANCOMYCIN;

EID: 0032872383     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007228     Document Type: Article

References (20)

1. Froland SS: Bacterial infections in the compromised host. Scand J Infect Dis 1984;43:7-16.
2. Johansson PJH, Ursing B: Infectious complications to granulocytopenia. Scand J Infect Dis 1984;16: 361-367.
3. Klastersky J: Empiric treatment of infection during granulocytopenia: A comprehensive approach. Infection 1989;17:59-94.
4. Pizzo PA: Empiric therapy and prevention of infection in the immunocompromised host; in Mandell GL, Bennett JE, Dolin R (eds); Principles and Practice of Infectious Disease, ed 4. New York, John Wiley, 1995;2686-2696.
5. Schimpff SC: Overview of empiric antibiotic therapy for the febrile neutropenic patient. Rev Infect Dis 1985;7:734-740.
6. Bodey GP; Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 1993;17(suppl 2):378-384.
7. Barradell LB, Bryson HM: Cefepime: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;47: 471-501.
8. Okamoto MP, Nakahiro RK, Chinn A, Bedikian A, Gill MA: Cefepime: A new fourth generation cephalosporin. Am J Hosp Pharm 1994;51: 463-477.
9. Cunha BA, Gill MV: Cefepime. Med Clin North Am 1995;79:721-732.
10. Fekete T, Tumah H, Woodwell J, Satishchandran V, Truant A, Axelrod P: Comparative susceptibilities of Klebsiella species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital. Am J Med 1996;100(suppl 6A):20-25.
11. Thornsberry C, Yee C: Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med 1996;100(suppl 6A):26-38.
12. Neu HC: Safety of cefepime: A new extended-spectrum parenteral cephalosporin. Am J Med 1996; 100(suppl 6A):68-78.
13. The EROTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978;137:14-29.
14. The EROTC International Antimicrobial Therapy Project Group: Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317:1692-1698.
15. EROTC International Antimicrobial Therapy Cooperative Group: Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990;26:569-574.
16. Bochud PY, Calandra T, Francioli P: Bacteremia due to viridans streptococci in neutropenic patients: A review. Am J Med 1994;97:256-264.
17. Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D: Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am J Med 1996; 100(suppl 6A):83-89.
18. Cordonnier C, Herbreccht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Ores J: Cefepime/amikin versus ceftazidime/amikin as empirical therapy for febrile episodes in neutropenic patients: A comparative study. Clin Infect Dis 1997;24: 41-51.
19. Eggimann P, Glauser MP, Aoun M, Meunier F, Calandra T: Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients. J Antimicrob Chemother 1993;32(suppl B): 151-163.
20. Yamamura D,Gucalp R, Carlisle P, Cimino M, Roberts J, Rotstein C: Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients. Antimicrob Agents Chemother 1997;41:1704-1708.